Enzyre is a developer of diagnostic technology.
Enzyre has raised $11.8M in total funding. The most recent round was Series A. The last funding was announced in November 2022.
Enzyre's investors include Novalis Biotechnology Incubation, i&i Biotech Fund, OostNL, Demcon, Takeda Ventures.
Enzyre is headquartered in Nijmegen, The Netherlands.
Enzyre is a developer of diagnostic technology.
Enzyre is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Enzyre — Funding & Investors." VCBacked, November 2, 2022, https://www.vcbacked.co/company/enzyre. Accessed August 13, 2026.
VCBacked. (2022). Enzyre — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/enzyre
{{cite web |title=Enzyre — Funding & Investors |url=https://www.vcbacked.co/company/enzyre |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated